| Old Articles: <Older 30601-30610 Newer> |
|---|
 |
The Motley Fool
June 11, 2008
Brian Lawler |
Dueling Fools: Pfizer Bear Is Pfizer ready for a comeback? The bearish opinion is that shares may be down, but the bleeding still isn't over.   |
The Motley Fool
June 11, 2008
Brian Orelli |
Dueling Fools: Pfizer Bull The bullish opinion on Pfizer is that this may be the best time to buy this stock. |
The Motley Fool
June 11, 2008
Brian Orelli |
Mylan Takes Generic Aim at Teva Mylan licenses a generic version of Teva's MS drug, Copaxone. Investors, take note. |
The Motley Fool
June 11, 2008
Toby Shute |
Potashapalooza! Investors are fired up about Agrium, the largest fertilizer retailer in the United States, as it raises guidance and looks to buy a new potash mine. |
The Motley Fool
June 11, 2008
Brian Lawler |
He Said, Biogen Said Pharmaceutical Biogen Idec's battle with Carl Icahn is coming to a head. |
The Motley Fool
June 11, 2008
Brian Lawler |
Pain and King Start the Countdown Who will win the race to get approval of an abuse-deterrent drug, Pain Therapeutics or King Pharmaceuticals? |
The Motley Fool
June 11, 2008
Brian Orelli |
Amylin's Down and Up on Diabetes Investors may be over-reacting to news both good and bad from Amylin Pharmaceuticals. |
The Motley Fool
June 11, 2008
Alyce Lomax |
Bigger's Not Always Better Gap's new CEO plans some serious overhauls to the 40 million square feet of space it leases for its stores. |
The Motley Fool
June 11, 2008
Christopher Barker |
POSCO Pushes Prices Up The South Korean steel giant worries that prices could impact demand. |
The Motley Fool
June 11, 2008
Tim Beyers |
Steve Jobs Punk'd? HP has introduced a second-generation touch model before the Mac's daddy -- typically the innovator in all things PC -- introduced its first. |
| <Older 30601-30610 Newer> Return to current articles. |
